Prime Medicine Inc (PRME) Implied Volatility Current

Tracking PRME implied volatility helps you identify when options premiums on Prime Medicine Inc are historically cheap or expensive, and where the best trades are hiding. Prime Medicine Inc implied volatility reflects the market's expectation of future price movement: when PRME IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Prime Medicine Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PRME, tracking metrics like PRME IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PRME signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PRME implied volatility sits today versus where it has been. Our scanner ranks Prime Medicine Inc implied volatility against its historical range, surfaces extremes in PRME IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Prime Medicine Inc IV is rich or cheap — measure it, then act on it.